000 04010nam a22005655i 4500
999 _c200457966
_d76178
003 DE-He213
005 20231109085845.0
007 cr nn 008mamaa
008 211216s2022 sz | s |||| 0|eng d
020 _a9783030844325
024 7 _a10.1007/978-3-030-84432-5
_2doi
040 _aTR-AnTOB
_beng
_cTR-AnTOB
_erda
060 0 0 _aQZ 202
072 7 _aMMF
_2bicssc
072 7 _aMED067000
_2bisacsh
072 7 _aMKF
_2thema
096 _aQZ202EBK
245 1 0 _aBiomarkers in Carcinoma of Unknown Primary
_h[electronic resource] /
_cedited by Sulen Sarioglu, Ozgul Sagol, Anil Aysal.
250 _a1st ed. 2022.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2022.
300 _a1 online resource
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aChapter 1) Definition of “Tissue-based Biomarker”, Its Place in Medicine and Molecular Pathology -- Chapter 2) The Concept and Mechanisms of Metastasis -- Chapter 3) Biomarkers in Skin Carcinomas -- Chapter 4) Biomarkers in Head and Neck Carcinomas -- Chapter 5) Biomarkers in Pulmonary Carcinomas -- Chapter 6) Biomarkers in Endocrine Organ Carcinomas -- Chapter 7) Biomarkers in Gastrointestinal System Carcinomas -- Chapter 8) Biomarkers in Hepatopancreatobiliary Carcinomas -- Chapter 9) Biomarkers in Urinary Tract and Male Genital System Carcinomas -- Chapter 10) Biomarkers in Gynecological Carcinomas -- Chapter 11) Biomarkers in Breast Carcinomas -- Chapter 12) Diagnostic Approach According to More Frequent Metastatic Sites-Liver, Lungs, Bone, Lymph Nodes -- Chapter 13) Diagnostic Approach According to Uncovered Metastatic Sites - Mediastinum-Timus, Peritoneum, Central Nervous System, Soft Tissue -- Chapter 14) Management of the Patients with Primary Unknown Carcinoma and the Role of Biomarkers -- Chapter 15) Treatment Approach to Carcinomas of Unknown Primary -- Appendix.
520 _aThis book aims to examine all immunohistochemical and molecular pathological biomarkers that can be useful and effective in patient diagnosis, prognosis and treatment decision, especially when faced with a carcinoma of unknown primary. For this purpose, epithelial malignancies of all systems and related biomarkers are examined one by one, and to look at the subject through the metastatic regions window, biomarkers that can be used to determine the primary focus for carcinomas seen in the areas most frequently metastasized are emphasized. With this bi-directional perspective, the reader is able to find biomarkers of any type of carcinoma on a system basis, as well as access to which biomarkers can be used when faced with a metastatic carcinoma. The importance of biomarkers in patient follow-up and treatment is also conveyed through the clinician's eye, and so biomarkers are handled with a holistic approach in all aspects. This book primarily targets pathologists, as well as clinicians (oncologists and surgeons) who manage cancer patients.
650 0 _aPathology.
650 0 _aOncology.
650 0 _aSurgery.
650 0 _aGastroenterology.
650 0 _aMedical radiology.
650 1 4 _aPathology.
650 2 4 _aOncology.
650 2 4 _aSurgery.
650 2 4 _aGastroenterology.
650 2 4 _aRadiation Oncology.
653 0 _aBiomarkers
700 1 _aSarioglu, Sulen.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aSagol, Ozgul.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aAysal, Anil.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
856 4 0 _uhttps://doi.org/10.1007/978-3-030-84432-5
_3Springer eBooks
_zOnline access link to the resource
942 _2NLM
_cEBK
041 _aeng